DK1126853T3 - Kontrolleret levering af antidepressine midler - Google Patents
Kontrolleret levering af antidepressine midlerInfo
- Publication number
- DK1126853T3 DK1126853T3 DK99971322T DK99971322T DK1126853T3 DK 1126853 T3 DK1126853 T3 DK 1126853T3 DK 99971322 T DK99971322 T DK 99971322T DK 99971322 T DK99971322 T DK 99971322T DK 1126853 T3 DK1126853 T3 DK 1126853T3
- Authority
- DK
- Denmark
- Prior art keywords
- antidepressants
- controlled delivery
- triazolones
- exemplified
- methods
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title abstract 2
- 229940005513 antidepressants Drugs 0.000 title abstract 2
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 phenoxyethyl substituted-1, 2, 4-triazolones Chemical class 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10667798P | 1998-11-02 | 1998-11-02 | |
| US10675898P | 1998-11-02 | 1998-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1126853T3 true DK1126853T3 (da) | 2006-08-14 |
Family
ID=26803899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99971322T DK1126853T3 (da) | 1998-11-02 | 1999-10-26 | Kontrolleret levering af antidepressine midler |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1126853B1 (da) |
| JP (1) | JP4711510B2 (da) |
| KR (2) | KR20070040421A (da) |
| AT (1) | ATE323493T1 (da) |
| AU (1) | AU1230800A (da) |
| CA (1) | CA2349719C (da) |
| CY (1) | CY1105463T1 (da) |
| DE (1) | DE69930952T2 (da) |
| DK (1) | DK1126853T3 (da) |
| ES (1) | ES2260962T3 (da) |
| HK (1) | HK1038515A1 (da) |
| PT (1) | PT1126853E (da) |
| WO (1) | WO2000025790A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040115262A1 (en) * | 2002-07-29 | 2004-06-17 | Frank Jao | Formulations and dosage forms for controlled delivery of topiramate |
| KR100699516B1 (ko) * | 2002-07-29 | 2007-03-26 | 알자 코포레이션 | 팔리페리돈의 조절 전달을 위한 방법 및 복용 형태 |
| US20050232995A1 (en) * | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| ATE544447T1 (de) | 2003-09-26 | 2012-02-15 | Alza Corp | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung |
| CA2540059C (en) * | 2003-09-26 | 2013-08-06 | Alza Corporation | Controlled release formulations exhibiting an ascending rate of release |
| CN101703488B (zh) * | 2008-12-16 | 2013-02-20 | 北京科信必成医药科技发展有限公司 | 具有润滑层结构的双层渗透泵控释片及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
| US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
| US5330762A (en) * | 1992-02-27 | 1994-07-19 | Alza Corporation | Tandospiaine antidepressive therapy |
| JP4015184B2 (ja) * | 1993-08-31 | 2007-11-28 | アルザ コーポレイション | 疎水性剤を含有するディスペンサー |
| US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| CA2160423A1 (en) * | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
| AU1767997A (en) * | 1996-02-15 | 1997-09-02 | Janssen Pharmaceutica N.V. | Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| WO1997047285A1 (en) * | 1996-06-10 | 1997-12-18 | Depomed, Inc. | Gastric-retentive oral controlled drug delivery system with enhanced retention properties |
| US6143325A (en) * | 1998-06-05 | 2000-11-07 | Bristol-Myers Squibb Company | Nefazodone dosage form |
-
1999
- 1999-10-26 DE DE69930952T patent/DE69930952T2/de not_active Expired - Lifetime
- 1999-10-26 JP JP2000579231A patent/JP4711510B2/ja not_active Expired - Lifetime
- 1999-10-26 KR KR1020077006959A patent/KR20070040421A/ko not_active Application Discontinuation
- 1999-10-26 EP EP99971322A patent/EP1126853B1/en not_active Expired - Lifetime
- 1999-10-26 ES ES99971322T patent/ES2260962T3/es not_active Expired - Lifetime
- 1999-10-26 AU AU12308/00A patent/AU1230800A/en not_active Abandoned
- 1999-10-26 KR KR1020017005537A patent/KR100734193B1/ko active IP Right Grant
- 1999-10-26 WO PCT/US1999/025017 patent/WO2000025790A1/en not_active Application Discontinuation
- 1999-10-26 PT PT99971322T patent/PT1126853E/pt unknown
- 1999-10-26 CA CA002349719A patent/CA2349719C/en not_active Expired - Lifetime
- 1999-10-26 AT AT99971322T patent/ATE323493T1/de active
- 1999-10-26 DK DK99971322T patent/DK1126853T3/da active
-
2002
- 2002-01-15 HK HK02100276A patent/HK1038515A1/xx not_active IP Right Cessation
-
2006
- 2006-07-07 CY CY20061100941T patent/CY1105463T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000025790A1 (en) | 2000-05-11 |
| AU1230800A (en) | 2000-05-22 |
| CY1105463T1 (el) | 2010-04-28 |
| CA2349719A1 (en) | 2000-05-11 |
| HK1038515A1 (en) | 2002-03-22 |
| DE69930952D1 (de) | 2006-05-24 |
| KR20070040421A (ko) | 2007-04-16 |
| EP1126853A1 (en) | 2001-08-29 |
| JP4711510B2 (ja) | 2011-06-29 |
| ES2260962T3 (es) | 2006-11-01 |
| CA2349719C (en) | 2009-06-02 |
| DE69930952T2 (de) | 2006-08-31 |
| EP1126853B1 (en) | 2006-04-19 |
| PT1126853E (pt) | 2006-07-31 |
| KR20010075677A (ko) | 2001-08-09 |
| ATE323493T1 (de) | 2006-05-15 |
| KR100734193B1 (ko) | 2007-07-02 |
| JP2002528505A (ja) | 2002-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200100293A (et) | Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II | |
| BR0012908A (pt) | Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana | |
| DE50202328D1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
| DK1459749T3 (da) | (S,S)-reboxetin til behandling af inkontinens | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| TR199800077T1 (xx) | Kontroll� ��z�len paroksetin terkipleri. | |
| RS49685B (sr) | Novi oblik jedinjenja | |
| DK1066269T3 (da) | Trisubstituerede 1,3,5-triazinderivater til behandling af HIV-infektioner | |
| IL147618A0 (en) | Method for treating chronic pain using mek inhibitors | |
| BR9703302A (pt) | Aparelho e método para a geração e uso de ìons férricos | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| HK1052708B (zh) | 谷氨酰胺-四氫噻唑和四氫化吡咯及其作為二肽基肽酶iv抑制劑的應用 | |
| HRP20010573B1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
| GB2387696A (en) | Real-time odds-based gaming | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| DK1033990T3 (da) | 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud | |
| ATE248822T1 (de) | Partikel mit kontrollierter freisetzungsrate | |
| DK1126853T3 (da) | Kontrolleret levering af antidepressine midler | |
| DE60112671D1 (de) | Gebogener, elastischer Zahnregulierungsring | |
| DK1347984T3 (da) | Fremgangsmåde til fremstilling af taxanderivater | |
| DK1177191T3 (da) | Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer | |
| ES2195405T3 (es) | Derivado de tiadiazol carboxamida, agente fitosanitario, y utilizacion. | |
| DK1390364T3 (da) | Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression | |
| FI980901A (fi) | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia | |
| DK1459748T3 (da) | (S,S)-reboxetin til behandling af perifer neuropati |